Furosemide Injection, Solution
Product Images NDC 55154-4452

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 55154-4452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C99a35c6 59d3 4fc5 B1d8 C9e3b22d1284 00

C99a35c6 59d3 4fc5 B1d8 C9e3b22d1284 00
This is a 40mg/4mL (10mg/mL) Furosemide Injection, supplied as 5 x 4 mL single-dose vials for intravenous or intramuscular use. The product insert contains prescribing information, precautions and warnings. Storage instructions are to store at controlled room temperature with permitted excursions, and to protect from light. Unused portions should be discarded, and the package is not child-resistant. This drug is manufactured by Baxter Pharmaceuticals India for Baxter Healthcare Corporation in Deerfield, IL, and is distributed by Cardinal Health in Dublin, OH. ML No.: G/28/1156.*
FDA Label Image

Spl-image-01-structure.jpg (Spl Image 01 Structure)

Spl-image-01-structure.jpg (Spl Image 01 Structure)
The given text provides information regarding the molecular formula and molecular weight of a compound. The compound has a molecular formula of CrzHi1CIN,055 and a molecular weight of 330.74.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.